Indefinite Delivery Contract SPE2DX18D2232

This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $999,999,999, serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of November 30, 2026 and does not utilize any set-aside designations, indicating open competition.

The task orders and delivery orders issued under this IDC cover a wide array of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other supplies across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The contract is focused on efficiently procuring these essential pharmaceutical and medical products to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. In addition to the DLA Troop Support Medical, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.